"A report from the AARP found that retail prices for more than one hundred specialty prescription drugs increased by nearly 11 percent in 2013. A separate report from the Government Accountability Office found that expenditures for new drugs in Medicare Part B were concentrated among a few drugs, mostly biologics, and most were costly for beneficiaries. The reports come as the Department of Health and Human Services held a forum Nov. 20 on prescription drug prices."